[Prevention with low dosage heparin. Selective or general?].
Schmitz-Huebner
U
U
Medizinische Klinik II, Klinikum Kreis Herford, Akademisches Lehrkranken-haus, Westfälischen Wilhelms-Universität Münster.
D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D006470:Hemorrhage / Q000097:blood / Q000139:chemically induced; D006493:Heparin / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D012307:Risk Factors; D013921:Thrombocytopenia / Q000097:blood / Q000139:chemically induced; D013923:Thromboembolism / Q000097:blood / Q000517:prevention & control*
D000925:Anticoagulants; D006493:Heparin